Achieving objective response in treatment of non-resectable neuroendocrine tumors does not predict longer time to progression compared to achieving stable disease | BMC Cancer | Full Text

Achieving objective response in treatment of non-resectable neuroendocrine tumors does not predict longer time to progression compared to achieving stable disease | BMC Cancer | Full Text

Achieving objective response in treatment of non-resectable neuroendocrine tumors does not predict longer time to progression compared to achieving stable disease

There are several treatment modalities for unresectable neuroendocrine tumors. Traditionally, the aim of these treatments has been to reduce the tumor load; referred to as objective response (OR). Less emphasi...

Authors:Espen Thiis-Evensen, Amalie Christine Poole, Hong-Thien Thi Nguyen and Jon Sponheim

Citation:BMC Cancer 2020 20:466

Content type:Research article

Published on: 24 May 2020

• ViewFull Text
 
• ViewPDF